PHARMACEUTICAL AGENT HAVING LONG-LASTING EFFECT OF TREATING ARTHRITIC DISORDERS
    1.
    发明申请
    PHARMACEUTICAL AGENT HAVING LONG-LASTING EFFECT OF TREATING ARTHRITIC DISORDERS 有权
    具有治疗神经疾病长期作用的药物代理

    公开(公告)号:US20110053885A1

    公开(公告)日:2011-03-03

    申请号:US12448064

    申请日:2007-12-06

    IPC分类号: A61K31/715 A61P19/02

    摘要: The present invention relates to an injection solution for intra-articular administration for treating arthritic disorders comprising a cross-linked hyaluronic acid derivative wherein part of functional groups of a hyaluronic acid are cross-linked with a cross-linking group to the extent of 0.6 to 15% of cross-linking extent as an active ingredient in an amount having a long-lasting analgesic effect and a pharmaceutically acceptable carrier, and an analgesic composition for suppressing a cartilage degeneration caused by arthritic disorders or a composition for suppressing a cartilage degeneration or an inflammation of synovium caused by arthritic disorders each comprising the cross-linked hyaluronic acid derivative and a pharmaceutically acceptable carrier.

    摘要翻译: 本发明涉及用于治疗关节炎疾病的关节内给药的注射液,其包含交联的透明质酸衍生物,其中透明质酸的官能团的一部分与交联基团交联至0.6〜 具有持久镇痛效果的量的作为活性成分的交联程度的15%和药学上可接受的载体,以及用于抑制由关节炎病症引起的软骨退化的镇痛组合物或用于抑制软骨退化的组合物或 由关节炎病症引起的滑膜的炎症各自包含交联的透明质酸衍生物和药学上可接受的载体。

    Pharmaceutical agent having long-lasting effect of treating arthritic disorders
    2.
    发明授权
    Pharmaceutical agent having long-lasting effect of treating arthritic disorders 有权
    具有治疗关节炎疾病长期作用的药剂

    公开(公告)号:US08889652B2

    公开(公告)日:2014-11-18

    申请号:US12448064

    申请日:2007-12-06

    摘要: The present invention relates to an injection solution for intra-articular administration for treating arthritic disorders comprising a cross-linked hyaluronic acid derivative wherein part of functional groups of a hyaluronic acid are cross-linked with a cross-linking group to the extent of 0.6 to 15% of cross-linking extent as an active ingredient in an amount having a long-lasting analgesic effect and a pharmaceutically acceptable carrier, and an analgesic composition for suppressing a cartilage degeneration caused by arthritic disorders or a composition for suppressing a cartilage degeneration or an inflammation of synovium caused by arthritic disorders each comprising the cross-linked hyaluronic acid derivative and a pharmaceutically acceptable carrier.

    摘要翻译: 本发明涉及用于治疗关节炎疾病的关节内给药的注射液,其包含交联的透明质酸衍生物,其中透明质酸的官能团的一部分与交联基团交联至0.6〜 具有持久镇痛效果的量的作为活性成分的交联程度的15%和药学上可接受的载体,以及用于抑制由关节炎病症引起的软骨退化的镇痛组合物或用于抑制软骨退化的组合物或 由关节炎病症引起的滑膜的炎症各自包含交联的透明质酸衍生物和药学上可接受的载体。

    AGENT FOR APPLYING TO MUCOSA AND METHOD FOR THE PRODUCTION THEREOF
    6.
    发明申请
    AGENT FOR APPLYING TO MUCOSA AND METHOD FOR THE PRODUCTION THEREOF 审中-公开
    适用于MUCOSA的代理及其生产方法

    公开(公告)号:US20150196574A1

    公开(公告)日:2015-07-16

    申请号:US14600558

    申请日:2015-01-20

    IPC分类号: A61K31/7008

    摘要: An agent for applying to mucosa capable of persistently exerting a therapeutic effect on disorders such as inflammation and lesions in the mucosa even by a lower frequency of administration because the agent can stay at a diseased site for a long period of time by exhibiting a high staying properly in a mucosal epithelial layer is provided, said agent for application to mucosa containing glycosaminoglycan (GAG) into which a hydrophobic group is introduced via a binding chain, as an active ingredient.

    摘要翻译: 一种适用于粘膜的药剂,即使是较低的给药频率也能够持续地对诸如炎症和粘膜中的病变的疾病施加治疗效果,因为该药剂可以通过显示高停留时间长时间地停留在患病部位 适当地在粘膜上皮层中适当地施用所述用于通过结合链引入疏水基团的含有糖胺聚糖(GAG)的粘膜作为活性成分。

    Bonding method of dissimilar materials made from metals and bonding structure thereof
    7.
    发明授权
    Bonding method of dissimilar materials made from metals and bonding structure thereof 有权
    由金属制成的不同材料的接合方法及其结合结构

    公开(公告)号:US08507825B2

    公开(公告)日:2013-08-13

    申请号:US13248141

    申请日:2011-09-29

    IPC分类号: B23K11/11

    摘要: Disclosed is a bonding method for dissimilar materials made from metals and its resulting structures. The materials to be bonded are formed by layering three or more sheets such that a dissimilar material interface and a same material interface are formed. A first current is conducted between a three-sheet layered plate material wherein an aluminum alloy plate, a zinc plated steel plate and a bare steel plate, for example, are layered in order. A nugget is formed in an interface between the zinc plated steel plate and the bare steel plate, which are the same materials. Then, a second current greater than the first current is conducted, and a nugget is formed in an interface between the aluminum alloy plate and the zinc plated steel plate.

    摘要翻译: 公开了一种用金属制成的不同材料及其结构的接合方法。 要结合的材料通过层叠三个或更多个片材形成,使得形成不同材料界面和相同的材料界面。 第一电流在例如铝合金板,镀锌钢板和裸钢板之间的三层叠层板材之间进行。 在镀锌钢板和裸钢板之间的界面上形成熔核,这是相同的材料。 然后,进行大于第一电流的第二电流,并且在铝合金板和镀锌钢板之间的界面中形成熔核。

    Bonding method of dissimilar materials made from metals and bonding structure thereof
    8.
    发明授权
    Bonding method of dissimilar materials made from metals and bonding structure thereof 有权
    由金属制成的不同材料的接合方法及其结合结构

    公开(公告)号:US08058584B2

    公开(公告)日:2011-11-15

    申请号:US12049758

    申请日:2008-03-17

    IPC分类号: B23K11/16

    摘要: Disclosed is a bonding method for dissimilar materials made from metals and its resulting structures. The materials to be bonded are formed by layering three or more sheets such that a dissimilar material interface and a same material interface are formed. A first current is conducted between a three-sheet layered plate material wherein an aluminum alloy plate, a zinc plated steel plate and a bare steel plate, for example, are layered in order. A nugget is formed in an interface between the zinc plated steel plate and the bare steel plate, which are the same materials. Then, a second current greater than the first current is conducted, and a nugget is formed in an interface between the aluminum alloy plate and the zinc plated steel plate.

    摘要翻译: 公开了一种用金属制成的不同材料及其结构的接合方法。 要结合的材料通过层叠三个或更多个片材形成,使得形成不同材料界面和相同的材料界面。 第一电流在例如铝合金板,镀锌钢板和裸钢板之间的三层叠层板材之间进行。 在镀锌钢板和裸钢板之间的界面上形成熔核,这是相同的材料。 然后,进行大于第一电流的第二电流,并且在铝合金板和镀锌钢板之间的界面中形成熔核。